JENNEREX, INC.

Profile

Company Names

JENNEREX, INC.

Addresses

450 SANSOME STREET, 16TH FLOOR, SAN FRANCISCO, CA 94111

450 SANSOME STREET, 16TH FL, SAN FRANCISCO, CA 94111

575 MARKET STREET, 8TH FL, SAN FRANCISCO, CA 94105

Phone Numbers

415-281-8886

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$10,351,369.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2011-09-09 
$1,750,006.00 
$1,750,006.00 
$0.00 
Equity 
1
2011-07-06 
$8,601,363.00 
$10,000,000.00 
$1,398,637.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DR. JOHN 
C 
BELL 
DIRECTOR
JENNEREX, INC.
JOHN 
 
BELL 
DIRECTOR
JENNEREX, INC.   |  SOURCE ROCK ROYALTIES LTD.   |  CULTIVATE MUSIC, INC.   |  GESTALT DIAGNOSTICS, LLC   |  CURE PHARMACEUTICAL HOLDING CORP.   |  PRIMETIME HOLDINGS INC.   |  IMMUNOCORE HOLDINGS PLC   |  NEVIS BRANDS INC.   |  TAMBORAN RESOURCES CORP
PETER 
D 
CHARBONNEAU 
DIRECTOR
JENNEREX, INC.
HELENA 
 
CHAYE 
EXECUTIVE OFFICER
JENNEREX, INC.
DR. TERRY 
 
HERMISTON 
DIRECTOR
JENNEREX, INC.
HOYOUNG 
 
HUH 
DIRECTOR
CALIBRA MEDICAL, INC.   |  JENNEREX, INC.   |  CYTOMX THERAPEUTICS, INC.   |  ANTRIABIO, INC.   |  RESET THERAPEUTICS, INC.   |  NUVESSE SKIN THERAPIES, INC.   |  JUUL LABS, INC.   |  REZOLUTE, INC.   |  EIDOS THERAPEUTICS, INC.   |  PLIANT THERAPEUTICS, INC.   |  AKARI THERAPEUTICS PLC
DAVID 
 
KIRN 
EXECUTIVE OFFICER, DIRECTOR
JENNEREX, INC.   |  4D MOLECULAR THERAPEUTICS INC   |  BENEVIR BIOPHARM, INC.
DAVID 
H 
KIRN 
EXECUTIVE OFFICER, DIRECTOR
JENNEREX, INC.
LARA 
 
LONGPRE 
EXECUTIVE OFFICER
JENNEREX, INC.   |  MIRUM PHARMACEUTICALS, INC.
BRENNAN 
 
MULCAHY 
DIRECTOR
JENNEREX, INC.
BRENNAN 
R 
MULCAHY 
DIRECTOR
JENNEREX, INC.
MARTIN 
 
MURPHY 
DIRECTOR
ALDAGEN INC   |  JENNEREX, INC.   |  INTEGRATED ENDOSCOPY, INC.   |  CAMBRIDGE EPIGENETIX LTD   |  CLADE THERAPEUTICS, INC.   |  AUTOLUS THERAPEUTICS PLC
KEN 
 
NEWPORT 
EXECUTIVE OFFICER, DIRECTOR
JENNEREX, INC.   |  VIRICA BIOTECH INC.
GREGORY 
 
SCHAFER 
EXECUTIVE OFFICER
JENNEREX, INC.   |  ADURO BIOTECH, INC.   |  CAPRICOR THERAPEUTICS, INC.
BARRY 
 
SHERMAN 
DIRECTOR
JENNEREX, INC.   |  ANTRIABIO, INC.
DANIEL 
K 
SPIEGELMAN 
DIRECTOR
JENNEREX, INC.
DR. HARTLEY 
 
STERN 
DIRECTOR
JENNEREX, INC.
RON 
 
VERED 
DIRECTOR
JENNEREX, INC.   |  CERTIRX CORP   |  EXODOS LIFE SCIENCES LIMITED PARTNERSHIP   |  ACHELIOS THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-10-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-09-09 
2011-08-18
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-06 
2011-07-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#